Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.8 -3.55% -0.14
TENX closed down 3.55 percent on Friday, November 16, 2018, on 57 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TENX trend table...

Date Alert Name Type % Chg
Nov 16 180 Bearish Setup Bearish Swing Setup 0.00%
Nov 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Nov 16 Outside Day Range Expansion 0.00%
Nov 16 Wide Bands Range Expansion 0.00%
Nov 16 Oversold Stochastic Weakness 0.00%
Nov 15 Stochastic Buy Signal Bullish -3.55%
Nov 15 Calm After Storm Range Contraction -3.55%
Nov 15 Narrow Range Bar Range Contraction -3.55%
Nov 15 NR7 Range Contraction -3.55%
Nov 15 Lower Bollinger Band Walk Weakness -3.55%

Older signals for TENX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Is TENX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 12.63
52 Week Low 3.75
Average Volume 9,070
200-Day Moving Average 6.0129
50-Day Moving Average 4.9075
20-Day Moving Average 4.6018
10-Day Moving Average 4.259
Average True Range 0.3222
ADX 19.66
+DI 26.344
-DI 24.4699
Chandelier Exit (Long, 3 ATRs ) 5.4234
Chandelier Exit (Short, 3 ATRs ) 4.7166
Upper Bollinger Band 5.6013
Lower Bollinger Band 3.6023
Percent B (%b) 0.1
BandWidth 43.439524
MACD Line -0.3181
MACD Signal Line -0.2192
MACD Histogram -0.0989
Fundamentals Value
Market Cap 107.31 Million
Num Shares 28.2 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -2.66
Price-to-Sales 0.00
Price-to-Book 1.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.30
Resistance 3 (R3) 4.35 4.24 4.21
Resistance 2 (R2) 4.24 4.11 4.21 4.18
Resistance 1 (R1) 4.02 4.04 3.97 3.97 4.16
Pivot Point 3.91 3.91 3.88 3.88 3.91
Support 1 (S1) 3.69 3.78 3.64 3.64 3.44
Support 2 (S2) 3.58 3.71 3.55 3.42
Support 3 (S3) 3.36 3.58 3.39
Support 4 (S4) 3.31